AmerisourceBergen (NYSE:ABC)…

AmerisourceBergen (NYSE:ABC) issued an update on its FY 2022 earnings guidance on Monday morning. The company provided earnings per share guidance of $10.600-$10.900 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $10.690. The company issued revenue guidance of -.

ABC stock traded up $0.52 during midday trading on Tuesday, hitting $139.93. The stock had a trading volume of 19,422 shares, compared to its average volume of 1,097,526. The firm has a market cap of $29.12 billion, a P/E ratio of 18.08, a price-to-earnings-growth ratio of 1.56 and a beta of 0.48. The company has a current ratio of 0.95, a quick ratio of 0.57 and a debt-to-equity ratio of 10.67. AmerisourceBergen has a 1-year low of $100.71 and a 1-year high of $140.24. The business has a fifty day moving average price of $129.66 and a two-hundred day moving average price of $124.66.

AmerisourceBergen (NYSE:ABC) last posted its quarterly earnings results on Wednesday, February 2nd. The company reported $2.58 earnings per share for the quarter, meeting the consensus estimate of $2.58. The firm had revenue of $59.63 billion during the quarter, compared to the consensus estimate of $59.62 billion. AmerisourceBergen had a net margin of 0.73% and a return on equity of 543.21%. The business’s revenue was up 13.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.18 earnings per share. On average, equities analysts anticipate that AmerisourceBergen will post 10.75 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, February 28th. Stockholders of record on Monday, February 14th will be given a dividend of $0.46 per share. This represents a $1.84 annualized dividend and a dividend yield of 1.31%. The ex-dividend date is Friday, February 11th. AmerisourceBergen’s payout ratio is presently 23.87%.


Fortune 500 Companies, Semiconductor producers, and even some of the largest sportswear manufacturers are all betting big by investing in a market Bloomberg Intelligence says could be worth $800 Billion by 2024.

Get the free report with the 4 most promising stocks to capitalize on the groundbreaking Metaverse.

A number of research firms have weighed in on ABC. Morgan Stanley boosted their target price on shares of AmerisourceBergen from $141.00 to $142.00 and gave the company an overweight rating in a research note on Friday, December 17th. Robert W. Baird boosted their target price on shares of AmerisourceBergen from $175.00 to $179.00 in a research note on Thursday, February 3rd. Barclays boosted their target price on shares of AmerisourceBergen from $135.00 to $152.00 and gave the company an equal weight rating in a research note on Tuesday, January 11th. Mizuho boosted their target price on shares of AmerisourceBergen from $130.00 to $139.00 and gave the company a neutral rating in a research note on Thursday, February 3rd. Finally, Scotiabank cut shares of AmerisourceBergen from an outperform rating to a sector perform rating in a research note on Thursday, January 6th. Four analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of Buy and a consensus target price of $151.43.

In other news, EVP Gina Clark sold 16,027 shares of the firm’s stock in a transaction dated Friday, November 12th. The shares were sold at an average price of $125.83, for a total value of $2,016,677.41. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Lazarus Krikorian sold 11,653 shares of the firm’s stock in a transaction dated Thursday, February 3rd. The stock was sold at an average price of $138.14, for a total transaction of $1,609,745.42. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 163,566 shares of company stock worth $21,544,909. 28.40% of the stock is owned by insiders.

About AmerisourceBergen

AmerisourceBergen Corp. engages in the provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, and long-term care and alternate site pharmacies.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]

Should you invest $1,000 in AmerisourceBergen right now?

Before you consider AmerisourceBergen, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and AmerisourceBergen wasn’t on the list.

While AmerisourceBergen currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.

View The 5 Stocks Here


Hippo Sighting Report

Help us out, we really appreciate it.

Help contribute to our research, and let us know if you have seen similar situations that we may have missed. Our team will review the details you provide and add to our main list once we verify the information.

stay informed

Subscribe and get the updated Hippo List.

Get notified when we release our updated lists by email.

Make a Donation

Thank you for subscribing!

We will send you an email to confirm your details.  Welcome aboard!

Thanks for sending us your report.

We will review your information, and publish in on our list once we validate the details.